Similarly, thrombocytopenia after intravenous Ad5 vector injection was prevented by the inclusion of mutations in the adenovirus that block its ability to bind to CXADR on host cells and instead redirect cell entry via integrin α(v)β(6) [112]. Here, CXADR is linked to Thrombocytopenia.